COVID-19 and Fulminant Clostridium difficile Colitis Co-Infection

European Journal of Case Reports in Internal Medicine

Nismat Javed¹  Abu Baker Sheikh²  Rahul Shekhar³  Ali Hamza Khair⁴  Abdul Ahad Ehsan Sheikh⁵  Ishan Shah⁶ 

[1] Shifa College of Medicine, Shifa Tameer-e-Millat University, Islamabad, Pakistan;University of New Mexico Health Sciences Center, Department of Internal Medicine, Albuquerque, NM, USA ;Division of Hospital Medicine, University of New Mexico School of Medicine, Department of Internal Medicine, Albuquerque, NM, USA;Shifa College of Medicine, Shifa Tameer-e-Millat University, Islamabad, Pakistan;The Wright Center for Graduate Medical Education, Department of Internal Medicine, Scranton, PA, USA;University of New Mexico Health Sciences Center, Department of Internal Medicine, Albuquerque, NM, USA;

关键词: covid-19;    antibiotics;    microbial resistance;    clostridium difficile;   

DOI  :  10.12890/2021_002771

来源: DOAJ

【 摘 要 】

The development of Clostridium difficile infection in COVID-19 patients is an understudied complication of the disease. Herein, we present the case of a 46-year-old man who developed severe healthcare-associated C. difficile infection leading to toxic megacolon and perforation in the setting of COVID-19 infection. It is important to continue to follow guidelines regarding antibiotics in healthcare settings to prevent such complications.

【 授权许可】

Unknown